Ilan Ganot
Net Worth

Last updated:

What is Ilan Ganot net worth?

The estimated net worth of Mr. Ilan Ganot is at least $5,982,779 as of 2 May 2024. He owns shares worth $55,616 as insider, has earned $122,413 from insider trading and has received compensation worth at least $5,804,750 in Solid Biosciences Inc..

What is the salary of Ilan Ganot?

Mr. Ilan Ganot salary is $829,250 per year as Co-founder, Pres, Chief Executive Officer & Director in Solid Biosciences Inc..

How old is Ilan Ganot?

Mr. Ilan Ganot is 51 years old, born in 1974.

What stocks does Ilan Ganot currently own?

As insider, Mr. Ilan Ganot owns shares in one company:

Company Title Shares Price per share Total value
Solid Biosciences Inc. (SLDB) Co-founder, Pres, Chief Executive Officer & Director 9,507 $5.85 $55,616

What does Solid Biosciences Inc. do?

Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candidate for the treatment of duchenne muscular dystrophy. It also engages in developing of platform technologies, including dual gene expression, a technology for packaging multiple transgenes into one vector, as well as novel capsids. The company has collaboration and license agreement with Ultragenyx Pharmaceutical Inc. to develop and commercialize new gene therapies for Duchenne Muscular Dystrophy. Solid Biosciences Inc. was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.

SLDB logo
SLDB
Solid Biosciences Inc.
$5.85

Ilan Ganot insider trading

Solid Biosciences Inc.

Mr. Ilan Ganot has made 12 insider trades between 2018-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 50,000 units of SLDB stock on 15 Nov 2018. As of 2 May 2024 he still owns at least 9,507 units of SLDB stock.

Transaction Date Security Shares Price per share Total value Source
Option
Restricted Stock Units 1,553 N/A N/A
Option
Common Stock 1,553 N/A N/A
Sale
Common Stock 462 $10.33 $4,772
Sale
Common Stock 139 $7.99 $1,111
Option
Restricted Stock Units 3,883 N/A N/A
Option
Restricted Stock Units 388 N/A N/A
Option
Common Stock 388 N/A N/A
Option
Common Stock 3,883 N/A N/A
Sale
Common Stock 1,142 $5.3 $6,053
Option
Common Stock 2,993 N/A N/A
Option
Restricted Stock Units 2,993 N/A N/A
Option
Common Stock 1,583 N/A N/A
Option
Restricted Stock Units 1,583 N/A N/A
Option
Common Stock 1,583 N/A N/A
Option
Restricted Stock Units 1,583 N/A N/A
Option
Common Stock 1,583 N/A N/A
Option
Restricted Stock Units 1,583 N/A N/A
Sale
Common Stock 487 $4.85 $2,364
Option
Restricted Stock Units 1,553 N/A N/A
Option
Common Stock 1,553 N/A N/A
Option
Common Stock 1,584 N/A N/A
Option
Restricted Stock Units 1,584 N/A N/A
Option
Restricted Stock Units 388 N/A N/A
Option
Common Stock 388 N/A N/A
Option
Restricted Stock Units 3,883 N/A N/A
Option
Common Stock 3,883 N/A N/A
Sale
Common Stock 141 $7.49 $1,056
Sale
Common Stock 1,382 $7.49 $10,351
Sale
Common Stock 463 $1.12 $519
Sale
Common Stock 457 $7.66 $3,501
Sale
Common Stock 10,713 $6.14 $65,778
Option
Restricted Stock Units 35,500 N/A N/A
Option
Common Stock 35,500 N/A N/A
Sale
Common Stock 299 N/A N/A
Option
Common Stock 800 N/A N/A
Option
Restricted Stock Units 800 N/A N/A
Sale
Common Stock 11,124 $2.42 $26,909
Option
Common Stock 35,500 N/A N/A
Option
Restricted Stock Units 35,500 N/A N/A
Option
Common Stock 800 N/A N/A
Option
Restricted Stock Unit 800 N/A N/A
Sale
Common Stock 50,000 N/A N/A

Solid Biosciences key executives

Solid Biosciences Inc. executives and other stock owners filed with the SEC: